At Hevert, the specific support of diverging customer groups such as drugstores, doctors, practitioners of natural therapeutics, pharmaceutical technical assistants and end users represent critical core processes. A more efficient and leaner mapping of processes, while driving growth and internationalization forward; these were the demands Hevert-Arzneimittel made on the censhare solution.
Exactly the Right Dose of Software
Hevert is building a healthy international communications system, transporting its knowledge and expertise both quickly and easily via censhare.
1
comprehensive solution, integrated in a single system
1
single location for content from creation to publishing
1
catalog containing all information on medicines, ingredients and therapy
We are able to transport our knowledge very well and very quickly with censhare.
Managing Director, Hevert
0:00 / 0:00
Improved process transparency
One of Hevert’s goals was to enable communication across more channels and languages with the same number of employees and external partners. In addition, Hevert was able to improve the transparency of the entire process with censhare. Today Hevert’s employees know far more about one another and their activities and are therefore better able to judge the impact of their own actions on other departments.
censhare was implemented to help us handle processes more rapidly and to higher quality levels, thereby reducing costs by saving staff time input and avoiding unnecessary corrections.
Managing Director, Hevert
About Hevert
Fielding a portfolio of more than 100 medicines. Hevert ranks as one of the leading homeopathic manufacturers worldwide. Founded in the year 1956, today’s Hevert-Arzneimittel is a family owned and managed company with 120 employees. The company generated sales of EUR 20 million in 2013 (+15.8 %). Continuing international growth is a cornerstone of the company’s success.
Solutions for manufacturers:
censhare helps transform the way a manufacturer operates, helping it reap all the benefits of the digital age.
Want to learn more?
